Pregnancy: There are no adequate data from the use of voriconazole in pregnant women. Vortimal must not be used during pregnancy unless the benefit to the mother clearly outweighs the potential risk to the foetus.
Women of child-bearing potential: Women of child-bearing potential must always use effective contraception during treatment.
Breastfeeding: The excretion of voriconazole into breast milk has not been investigated. Breastfeeding must be stopped on initiation of treatment with Vortimal.